RYBREVANT

Indicated For

EGFR-positive NSCLC

About This Medication

# Johnson & Johnson Patient Assistance Foundation Patient Guide: How to Get RYBREVANT (amivantamab-vmjw) at Low or No Cost RYBREVANT (amivantamab-vmjw) is a prescription medication used to treat certain types of advanced lung cancer, and the **Johnson & Johnson Patient Assistance Foundation** offers it at no cost to eligible uninsured or underinsured patients who meet income and other criteria.[1][2] This guide explains everything you need to know to apply, qualify, and receive your medication, making the process simple and stress-free for patients like you. ## About RYBREVANT (amivantamab-vmjw) **RYBREVANT** is an intravenous infusion therapy approved for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations, such as EGFR exon 20 insertion mutations, often after other treatments have failed.[1] It works by targeting proteins on cancer cells to stop their growth, offering a targeted approach for patients who have limited options. Administered by a healthcare provider in a clinical setting, RYBREVANT helps manage symptoms and potentially extend life for those with this serious condition. Always consult your doctor for personalized advice, as this guide focuses on assistance, not medical guidance. ## Who Qualifies for the Program? The **Johnson & Johnson Patient Assistance Foundation** provides free medication to U.S. residents (including territories like Puerto Rico) who are **uninsured, underinsured, or have government coverage** like Medicare, Medicaid, TRICARE, or VA benefits, and meet income limits.[1][2][5] You must be prescribed RYBREVANT by a U.S.-licensed outpatient healthcare provider and treated as an outpatient.[2] Key requirements include: - Living in the U.S. or U.S. territory. - Household income below program guidelines (detailed below). - For Medicare Part D patients: Not eligible for Low-Income Subsidy (if income ≤150% FPL) and spending >4% of gross annual household income on prescriptions.[2] This program bridges the gap for those facing high costs, ensuring access to vital therapy.[4] ## Income Eligibility Breakdown Eligibility is based on **household income**, with specific thresholds for individuals and couples, and flexibility up to $200,000 for larger families.[5] Provide proof like your most recent 1040 or 1040-SR tax return.[1] Here's a clear table: | Household Size | Annual Income Limit | |---------------|---------------------| | 1 (Individual) | $50,000 | | 2 (Couple) | $70,000 | | 3+ | Up to $200,000 (varies by family size; call for exacts) | **Notes**: Guidelines adjust for family size—contact the program for precise limits beyond couples. Puerto Rico residents need additional financial docs like Form 482.[1] Income is gross household, including all members.[2] ## Insurance Requirements The program serves **uninsured or underinsured patients**, including those with commercial, employer-sponsored, or government insurance that doesn't fully cover costs.[2][5][7] Submit copies of insurance cards (front/back) if applicable.[1] Medicare Part D patients must prove >4% income spent on drugs via pharmacy reports or EOBs.[2][7] No coverage? You're likely eligible if income qualifies. The program determines your status during review.[3] ## Step-by-Step Application Process Applying is straightforward with **multiple methods**: online, phone, download/fax forms.[1][2][3] Here's how: 1. **Gather Documents**: Proof of income (e.g., 1040 tax return), residency (e.g., utility bill), prescription from your doctor, insurance cards if any.[1] 2. **Get the Form**: Download from JJPatientAssistance.com or call (800) 652-6227 / 833-742-0791 (Mon-Fri, 8AM-8PM ET).[1][2] 3. **Complete Sections**: Patient info (name, DOB, address, phone), insurance details, doctor completes prescription page (one per med).[1] 4. **Sign Consents**: Review/sign Patient Consent and Authorization Forms online at JJPatientAssistance.com/Consent and /PA (or include if done).[1] 5. **Submit**: Upload online at JJPatientAssistance.com, fax to 833-512-0497, or mail. Doctor signs page 3.[1][2][7] 6. **Follow Up**: Program reviews; missing info delays processing.[1] Your doctor must provide prescription details—fax if needed.[2] Assistance available via phone.[4] ## Timeline and Delivery **Processing takes 2-4 weeks** after complete submission.[1] Once approved, medication ships **directly to you** (or your address) at no cost, for up to 1 year.[2][5] Track via patient portal.[3] Reauthorization required annually.[7] ## Alternatives if Denied or Ineligible If denied (e.g., income too high), explore: - **J&J withMe**: Insurance help, copay support.[4] - **Medicine Assistance Tool (MAT.org)**: Searches other programs.[4] - **Independent foundations** supported by J&J.[4] - Simplefill or similar for application help.[5] - Doctor's office for samples or other PAPs.[7] No biosimilar alternatives for RYBREVANT currently.[ ] ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026 and is not official advice. Eligibility, terms, and income limits can change—verify with the **Johnson & Johnson Patient Assistance Foundation** at (800) 652-6227 or JJPatientAssistance.com.[1][2] Consult your healthcare provider before starting treatment. J&J reserves rights to modify program; not a guarantee of approval. Income proofs must be accurate; falsification disqualifies.[1][8] Word count: 1028.

Program information last verified: March 30, 2026